#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer recurrent Acute graft versus host disease in skin Behcet's syndrome Inclusion body myositis Ichthyosis Bronchopulmonary aspergillosis Juvenile chronic myelomonocytic leukaemia T-cell lymphoma Mitochondrial myopathy Hydrocephalus Hepatoblastoma Chronic inflammatory demyelinating polyradiculoneuropathy Orthostatic hypotension Hepatitis B Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital Splenic marginal zone lymphoma Uterine leiomyosarcoma – Life with Disease Leiomyosarcoma – Diagnostics Gaucher’s disease type I – Basic Information Waldenstrom’s macroglobulinaemia – Treatment Rhabdomyosarcoma – Basic Information Testicular leiomyosarcoma – Trials in Disease Myxofibrosarcoma – Life with Disease Angiosarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluocinolone Acetonide Eletriptan Eight Treg ANTIMETABOLITES Syn2 Indometacin Ph. Eur. Grwd5769 Acenocoumarol Keto-Isoleucine Calcium AZD1163 Ibuprofen Sodium Dihydrate GEN1078 VORMATRIGINE Potassium Canrenoate Idarubicin Gsk4532990A Olodaterol Betamethasone Sodium Phosphate Zimberelimab Dermatophagoides Farinae More therapies…

    Learn about Your Condition

    Uterine cancer Perthes disease Huntington's disease Micrographic skin surgery Trigeminal neuralgia Haemolytic uraemic syndrome Metastases to meninges Ocular hypertension Osteoarthritis Bladder cancer recurrent Tendon disorder Palpitations Cutaneous T-cell lymphoma Leiomyosarcoma Axial spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Fecal Microbiota Transplant with Atezolizumab and Bevacizumab for Liver Cancer Patients Unresponsive to Previous Immunotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Bevacizumab
    • Atezolizumab
    Austria

  • Study on the Safety and Tolerability of WVE-006 for Patients with Alpha-1 Antitrypsin Deficiency (AATD) Pi*ZZ

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Alpha-1 antitrypsin deficiency
    Investigated Drugs:
    • Wve-006
    Finland Germany

  • Title: Study of Solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety

    Not recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Solrikitug
    Belgium Italy The Netherlands Poland Spain

  • Safety Study of Tradipitant for Patients with Idiopathic or Diabetic Gastroparesis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic gastroparesis
    • Impaired gastric emptying
    Investigated Drugs:
    • Tradipitant
    Belgium Germany

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health

    Not recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Resmetirom
    Belgium France Germany Italy Spain
Previous Page
1 … 64 65 66 67 68 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!